Qiming U.S. Healthcare GP II, LLC is 10% Owner at Jasper Therapeutics, Inc. (JSPR). They have made 1 open-market trade across 1 company since 2023, most recently 2023-01-27.
CIK 0001868862
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $4.0M since 2023, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| JSPR | 8,519,648 | $4.1M |
Shares reported on the most recent Form 4, priced at the 2023-04-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| JSPR | BUY | 2023-01-27 | 2023-04-11 | $1.50 | $4.0M | -11.0% | -3.2% | -10.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.